SLC39A10 and glioblastoma: used bioinformatics to identify four survival-associated differentially expressed genes (OSMR, HOXC10, SCARA3, and SLC39A10) in glioblastomas and found that glioblastoma patients with abnormal HOXC10 expression had poor survival outcomes (42).